28 February 2003
Bioterrorism: are we prepared?
Bioterrorism: the current threat will take place on 3-4th April at the Royal Society of Medicine, in association with the New York Academy of Medicine. Speakers from both sides of the Atlantic include:
Would your doctor know what to do?
Dr Robyn Gershon, Columbia University Mailman School
of Public Health, USA, - Preparing Physicians and Public
Health Professionals
Diseases like smallpox, anthrax and plague have been
so rare in the past that for most doctors, learning how to
recognise and deal with them involves starting from scratch.
With many people people convinced that such an attack is only
a matter of time, is the UK health service prepared? Dr Gershon
will share information and practical advice based on her work
with physicians in New York, which highlighted how keen the
doctors were to learn but also how intensive training has
to be.
Would you know what to do? Scientific advice on the best way
to prepare for catastrophe
Dr Tom LaTourrette, RAND USA, - Citizen preparedness
One of the most frightening things about the bioterrorist
threat is its lack of predictability. Dr LaTourrette will
describe current planning within the US government along with
ongoing RAND research that addresses individual strategies
for catastrophic terrorist attacks. His focus will be on potential
scenarios involving chemical, biological, radiological, and
nuclear weapons and methods for developing effective strategies.
He will share a way of approaching individual preparedness
for a broad range of types of terrorist attacks.
Without biotech rules "literally everyone will be in lethal
danger"
Dr John Steinbruner, University of Maryland, USA, - Revealing results to the enemy
Medical and agricultural research into beneficial products
is unavoidably producing results that could be "exceedingly
dangerous," claims Dr Steinbruner. He argues that management
of increasingly powerful biotechnology requires protective
oversight on a global basis. He will suggest practical ways
of setting up an international body to license "highly consequential" research and regulate who is entitled to access its results.
If we fail to take the threat seriously now, he warns, terrorists
of the near future will be able to kill not tens of thousands,
but tens of millions of victims.
The inside story on the US anthrax attacks
Dr James M Hughes, Centers for Disease Control and
Prevention USA, - The Anthrax Story: what happened and
what we learned
What changes have been made since the anthrax attacks
in September 2001? Dr Hughes will describe the way the US
public health system responded then and the way attitudes
have changed since. He will argue that the anthrax threat
reinforced the need to improve surveillance, research, and
response mechanisms, not just to fight bioterrorism but also
to protect the public from naturally occurring infections,
especially emerging new diseases.
[ends]
